About
Looking for more information?
Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
INVESTOR PRESENTATION - Mayne Pharma Group Limited
Mayne Pharma Group Limited
Health
Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, NC, USA. Former Names Halcygen Pharmaceuticals Limited (HGN), 18/11/2010
Read moreMarket Cap
$596.07m
Price at Close
$0.355
4w avg. Volume
996.66k
4w avg. Turnover
$350.97k
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| +1.43% | 06 Jan 2021 |
| 0.00% | 17 Dec 2020 |
| +2.78% | 04 Dec 2020 |
| +2.78% | 04 Dec 2020 |
| +1.41% | 24 Nov 2020 |
| 0.00% | 23 Nov 2020 |
| -1.54% | 09 Nov 2020 |
| -3.13% | 25 Oct 2020 |
| -3.08% | 23 Oct 2020 |
| +3.13% | 14 Oct 2020 |
Market Data
Current Price
$0.355
52WK HIGH
$0.485
52WK LOW
$0.195
1YR RETURN
-26.80%
1YR RETURN VS. SECTOR
-63.63%
90 DAY RETURN
+10.94%
ASX RANK
357
/2,047
SECTOR RANK
21
/168
SHARES OUTSTANDING
1.68b
Mayne Pharma Group Limited
Health
Mayne Pharma Group Limited (MYX) is a pharmaceutical company that develops and manufactures branded and generic products, which it distributes directly or through distribution partners in Australia, USA, Europe and Asia. Mayne Pharma has two drug development and manufacturing facilities based in Salisbury, Australia and Greenville, NC, USA. Former Names Halcygen Pharmaceuticals Limited (HGN), 18/11/2010
Read moreMarket Cap
$596.07m
Price at Close
$0.355
4w avg. Volume
996.66k
4w avg. Turnover
$350.97k
ASX:MYX is not raising right now
Want to invest?
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia